About
Rob Scott served as Chief Medical Officer at AbbVie and currently holds the position of Chief Medical Officer and Head of R&D at ABIONYX Pharma, where the company is developing a sepsis therapy. He brings nearly four decades of executive leadership experience across drug discovery, development, strategic lifecycle planning, and medical affairs at major pharmaceutical and biotech companies, and maintains board and advisory positions at multiple biotech, venture capital, and private equity firms.
Experience
- ABIONYX PharmaChief Medical Officer & Head of R&Dcurrent2024 — present
- Confo TherapeuticsBoard Membercurrent2020 — present
- Draupnir BioBoard Membercurrent2020 — presentCopenhagen, Capital Region of Denmark, Denmark
- Variant BioBoard Membercurrent2020 — present
- OncoSpherixBoard Membercurrent2021 — presentAtlanta, Georgia, United States
- Bioethics InternationalAdvisorcurrent2017 — present
- Redx PharmaBoard Member2022 — 2024Manchester Area, United Kingdom
- ArisGlobalBoard Member2020 — 2024
- Windtree Therapeutics, Inc.Board Member2021 — 2024
- Morningside BioPharma AdvisoryStrategic Advisor2020 — 2023
- AbbVieChief Medical Officer, Head of Development2016 — 2020Greater Chicago Area
- Chicago Council on Science and Technology (C2ST)Board Member2019 — 2020Greater Chicago Area
- PhRMAR&D Leadership Forum2016 — 2020Greater Chicago Area
- TransCelerate BioPharma Inc.Board Member2016 — 2020Greater Chicago Area
- Kanan Therapeutics, Inc.Chairman of the Board2016 — 2018Los Angeles Metropolitan Area
- AmgenVice President, Global Development TA Head, Head Development Design Center2010 — 2016Los Angeles Metropolitan Area
- FDACommittee Member2012 — 2015Washington DC-Baltimore Area
- Cerenis TherapeuticsChief Medical Officer2008 — 2010Greater Toulouse Metropolitan Area
- AtheroGenicsChief Medical Officer, Executive Vice President of Research & Development2002 — 2007Atlanta Metropolitan Area
- PfizerVice President Cardiovascular & Metabolic Group1992 — 2002New York City Metropolitan Area
Education
- University of Cape TownMbChB, Medicine1977 — 1981
- University of Cape TownBSc, Microbiology and Biochemistry1974 — 1976
Skills & more
Nonprofit Organizations5Clinical Development99Clinical Trials99Pharmaceutical Industry97Drug Development85Biotechnology67Clinical Research40Regulatory Affairs35Drug Discovery35Medicine29Life Sciences30Diabetes20
+12 more
FDACommercializationPharmacologyStrategyPharmaceuticsMedical DevicesBiopharmaceuticalsTherapeutic AreasR&DMedical AffairsLifesciencesCardiologyFrom Rob's professional profile.
Colleagues at Apollo Health Ventures
Alex Strasser
Senior Associate at Apollo Health Ventures
Alexandra Bause
Co-Founder and Venture Partner at Apollo Health Ventures
Anela Vukoja
COO at Apollo Health Ventures
Anne Marije van Harten
Investment Director at Apollo Health Ventures
Antoine Boulanger
Partner at Apollo Health Ventures
Christopher R. Shepard
Venture Partner at Apollo Health Ventures
Dr. Alexandra Bause
Co-Founder & Venture Partner at Apollo Health Ventures
Dr. Gerd Hummel
Venture Partner at Apollo Health Ventures
Frequently asked questions
- Where does Rob Scott work?
- Rob Scott is Advisor at Apollo Health Ventures.
Same school
Also attended University of Cape Town154
Roelof BothaAdvisor & former Steward at Sequoia Capital; SpaceX board memberJames DetweilerVP of Investments at Felicis VenturesAvron MarcusInvestor at Index VenturesLaurel BowdenPartner at 83NorthAlan EzekowitzInvestor at Third Rock VenturesAndy VitusPartner at Scale Venture Partners
+ 148 more
Shared employers
Also worked at Confo Therapeutics4
Also worked at AbbVie40
Nick GasbarroChief of Staff at QED InvestorsManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next VenturesAndrew BierDigital Pharma Advisor at Excelerate Health VenturesShwen GweeDigital Pharma Advisor at Excelerate Health Ventures
+ 34 more
Also worked at Pfizer143
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpactJohn McKearnSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
+ 137 more
Also worked at Johnson & Johnson144
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture PartnersBrad H. ValeFounding General Partner at Treo Ventures, Llc
+ 138 more